Medicines Distribution Consents




794

NEW ZEALAND GAZETTE, No. 30

15 MARCH 2007

Product:
Quetapel
Active Ingredient:
Quetiapine fumarate 28.78mg equivalent to quetiapine 25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Merck Farma y Quimica SA, Poligono Merck, Barcelona, Spain

Product:
Quetapel
Active Ingredient:
Quetiapine fumarate 345.39mg equivalent to quetiapine 300mg
Dosage Form:
Tablet
New Zealand Sponsor:
Pacific Pharmaceuticals Limited
Manufacturer:
Merck Farma y Quimica SA, Poligono Merck, Barcelona, Spain

Product:
DBL® Flumazenil
Active Ingredient:
Flumazenil 0.5mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Mayne Pharma (NZ) Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
DBL® Flumazenil
Active Ingredient:
Flumazenil 1mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Mayne Pharma (NZ) Limited
Manufacturer:
Hameln Pharmaceuticals GmbH, Hameln, Germany

Dated this 9th day of March 2007.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1661

Consent to the Distribution of New Related Products

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Product:
Colgate Max Fresh – Citrus Blast
Active Ingredient:
Sodium fluoride 0.221%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer:
Colgate-Palmolive (Thailand) Limited, Amphur Muang, Chonburi, Thailand

Product:
Macleans Protect – Lemonmint
Active Ingredient:
Sodium fluoride 2.21mg/g
Dosage Form:
Toothpaste
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia

Dated this 9th day of March 2007.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1662

Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Proleukin
Active Ingredient:
Aldesleukin 18MIU
Dosage Form:
Powder for injection
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Chiron BV, Amsterdam, The Netherlands
Chiron Corporation, Emeryville, California, United States of America

Note: This consent is valid for two years from 27 January 2007.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 30


Gazette.govt.nz PDF NZ Gazette 2007, No 30





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 March 2007
Medicines, Consent, Distribution, Quetapel, DBL Flumazenil
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Related Products

🏥 Health & Social Welfare
9 March 2007
Medicines, Consent, Distribution, Colgate Max Fresh, Macleans Protect
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Renewal of Provisional Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 March 2007
Medicines, Provisional Consent, Renewal, Proleukin
  • DON MATHESON, Deputy Director-General, Public Health